康圣环球基因技术有限公司（09960）于2026年7月13日发布公告，披露于同日于香港联交所场内回购32,500股普通股，占该公司当日已发行股本（不包括库藏股）约0.00314%。每股回购价格介乎每股港币0.94港元至0.98港元，合计支付金额约30,709.25港元（约3.07万港元）。
公告指出，此次回购完成后，公司已发行股份数量变更为1,033,703,640股，公司库藏股数升至7,623,000股，合计股份总数则为1,041,326,640股。公司于2026年6月5日通过购回授权，授权总额为103,426,264股。截至本公告日期，合计已回购股份559,000股，约占购回授权通过日已发行股本的0.05405%。
公司表示，本次回购行为符合香港联合交易所有限公司证券上市规则的相关规定。公告由执行董事、首席财务官兼公司秘书柴海节签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.